Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
VHH-72-Fc
Potential treatment - pre-clinical evidence Experimental Antiviral May/05/2020
Tanespimycin
Potential treatment - pre-clinical evidence Experimental Antiviral May/05/2020
4A3
Potential treatment - pre-clinical evidence Experimental Antiviral May/03/2020
4A12
Potential treatment - pre-clinical evidence Experimental Antiviral May/03/2020
4D5
Potential treatment - pre-clinical evidence Experimental Antiviral May/03/2020
4A10
Potential treatment - pre-clinical evidence Experimental Antiviral May/03/2020
ABBV-744
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
AC-55541
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
4E2RCat
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Apicidin
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Verdinexor
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
WDB002
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
XL413
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
ZINC1775962367
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
ZINC4326719
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
ZINC4511851
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
ZINC95559591
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Zotatifin
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Sanglifehrin A
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Sapanisertib
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020